Skip to main content

Table 1 Characteristics of the patients

From: Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant

Variable

Total

Total patients

65

 Median Age (range)

45 (11–73)

 Male/female

48/17

Diagnosis

 AML

47

 MDS

5

 Lymphoma

6

 CML

2

 Other leukemia

5

Disease status before second HCT

 Remission

13

 Not in remission

52

Donor status

 MRD

33

 MUD

21

 Haplo-cord

11

Conditioning regimen for first HCT

 Myeloablative

19

 RIC

46

Conditioning regimen for second HCT

 Myeloablative

44

  Flu-Bu-Alemtuzumab

18

  TBI-based

7

  Bu/Cy

7

 RIC

21

  Flu-mel-Alemtuzumab

5

  Clo-mel-Alemtuzumab

7

  Flu-mel-ATG

7

  1. MRD matched related donor, MUD matched unrelated donor, MDS myelodysplastic syndrome